HK Stock MarketDetailed Quotes

BIOHEART-B (02185)

Watchlist
  • 4.030
  • +0.020+0.50%
Market Closed Apr 30 16:05 CST
980.97MMarket Cap-12.63P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

BIOHEART-B (02185) Income Statement

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q6)Jun 30, 2025
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
Turnover
--44.93M
--20.86M
----
----
----
----
----
----
----
----
Operating income
44.93M
20.86M
Cost of sales
---26.92M
---11.17M
----
----
----
----
----
----
----
----
Operating expenses
-26.92M
-11.17M
Gross profit
18.02M
9.7M
Selling expenses
---2.84M
---1.15M
----
----
----
----
----
----
----
----
Administrative expenses
-26.53%-24.98M
-36.80%-9.69M
62.67%-19.74M
77.08%-7.08M
43.96%-52.88M
42.61%-30.91M
51.71%-94.37M
48.48%-53.85M
-139.62%-195.42M
-5,082.70%-104.54M
Research and development expenses
-49.85%-61.89M
7.81%-20.09M
63.04%-41.3M
68.19%-21.79M
29.20%-111.74M
4.05%-68.5M
26.33%-157.83M
40.75%-71.39M
12.82%-214.23M
-893.78%-120.49M
Operating interest expense
----
----
----
----
----
----
----
---510K
---685K
----
Special items of operating profit
54.85%-14.1M
-41.98%716K
-42.07%-31.23M
-78.59%1.23M
-192.68%-21.99M
-43.37%5.76M
4,533.01%23.72M
549.96%10.18M
103.13%512K
-533.33%-2.26M
Operating profit
7.02%-85.79M
25.78%-20.52M
50.55%-92.27M
70.48%-27.64M
18.33%-186.61M
18.98%-93.64M
44.25%-228.48M
49.15%-115.58M
-19.25%-409.83M
-1,568.87%-227.28M
Financing cost
-13,559.38%-8.74M
-28,804.35%-6.65M
88.93%-64K
94.12%-23K
39.73%-578K
---391K
---959K
----
----
-773.08%-227K
Share of profits of associates
-0.81%-994K
61.27%-256K
39.62%-986K
39.08%-661K
-14.20%-1.63M
---1.09M
---1.43M
----
----
----
Share of profit from joint venture company
---473K
----
----
----
----
----
----
----
----
----
Earning before tax
-2.87%-96M
3.20%-27.42M
50.58%-93.32M
70.22%-28.33M
18.21%-188.82M
17.70%-95.12M
43.67%-230.87M
49.20%-115.58M
-20.43%-409.83M
-1,567.35%-227.51M
Tax
--27.57M
--686K
----
----
----
----
----
----
----
----
After-tax profit from continuing operations
26.67%-68.43M
5.62%-26.73M
50.58%-93.32M
70.22%-28.33M
18.21%-188.82M
17.70%-95.12M
43.67%-230.87M
49.20%-115.58M
-20.43%-409.83M
-1,567.35%-227.51M
Earning after tax
26.67%-68.43M
5.62%-26.73M
50.58%-93.32M
70.22%-28.33M
18.21%-188.82M
17.70%-95.12M
43.67%-230.87M
49.20%-115.58M
-20.43%-409.83M
-1,567.35%-227.51M
Minority profit
130.09%1.62M
119.20%479K
58.38%-5.38M
72.06%-2.5M
51.46%-12.93M
36.83%-8.93M
44.95%-26.63M
49.00%-14.14M
-227.51%-48.38M
---27.72M
Profit attributable to shareholders
20.34%-70.05M
-5.35%-27.21M
50.00%-87.94M
70.03%-25.83M
13.88%-175.89M
15.04%-86.19M
43.50%-204.24M
49.23%-101.44M
-11.04%-361.45M
-1,364.19%-199.79M
Basic earnings per share
19.44%-0.29
0.00%-0.11
50.00%-0.36
68.57%-0.11
14.29%-0.72
16.67%-0.35
48.78%-0.84
53.85%-0.42
31.09%-1.64
-0.91
Diluted earnings per share
19.44%-0.29
0.00%-0.11
50.00%-0.36
68.57%-0.11
14.29%-0.72
16.67%-0.35
48.78%-0.84
53.85%-0.42
31.09%-1.64
-0.91
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
--
--
Ernst & Young Huaming Accounting Firm (Special General Partnership)
--
Ernst & Young Huaming Accounting Firm (Special General Partnership)
--
Ernst & Young
--
Ernst & Young
--
(FY)Dec 31, 2025(Q6)Jun 30, 2025(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021
Turnover --44.93M--20.86M--------------------------------
Operating income 44.93M20.86M
Cost of sales ---26.92M---11.17M--------------------------------
Operating expenses -26.92M-11.17M
Gross profit 18.02M9.7M
Selling expenses ---2.84M---1.15M--------------------------------
Administrative expenses -26.53%-24.98M-36.80%-9.69M62.67%-19.74M77.08%-7.08M43.96%-52.88M42.61%-30.91M51.71%-94.37M48.48%-53.85M-139.62%-195.42M-5,082.70%-104.54M
Research and development expenses -49.85%-61.89M7.81%-20.09M63.04%-41.3M68.19%-21.79M29.20%-111.74M4.05%-68.5M26.33%-157.83M40.75%-71.39M12.82%-214.23M-893.78%-120.49M
Operating interest expense -------------------------------510K---685K----
Special items of operating profit 54.85%-14.1M-41.98%716K-42.07%-31.23M-78.59%1.23M-192.68%-21.99M-43.37%5.76M4,533.01%23.72M549.96%10.18M103.13%512K-533.33%-2.26M
Operating profit 7.02%-85.79M25.78%-20.52M50.55%-92.27M70.48%-27.64M18.33%-186.61M18.98%-93.64M44.25%-228.48M49.15%-115.58M-19.25%-409.83M-1,568.87%-227.28M
Financing cost -13,559.38%-8.74M-28,804.35%-6.65M88.93%-64K94.12%-23K39.73%-578K---391K---959K---------773.08%-227K
Share of profits of associates -0.81%-994K61.27%-256K39.62%-986K39.08%-661K-14.20%-1.63M---1.09M---1.43M------------
Share of profit from joint venture company ---473K------------------------------------
Earning before tax -2.87%-96M3.20%-27.42M50.58%-93.32M70.22%-28.33M18.21%-188.82M17.70%-95.12M43.67%-230.87M49.20%-115.58M-20.43%-409.83M-1,567.35%-227.51M
Tax --27.57M--686K--------------------------------
After-tax profit from continuing operations 26.67%-68.43M5.62%-26.73M50.58%-93.32M70.22%-28.33M18.21%-188.82M17.70%-95.12M43.67%-230.87M49.20%-115.58M-20.43%-409.83M-1,567.35%-227.51M
Earning after tax 26.67%-68.43M5.62%-26.73M50.58%-93.32M70.22%-28.33M18.21%-188.82M17.70%-95.12M43.67%-230.87M49.20%-115.58M-20.43%-409.83M-1,567.35%-227.51M
Minority profit 130.09%1.62M119.20%479K58.38%-5.38M72.06%-2.5M51.46%-12.93M36.83%-8.93M44.95%-26.63M49.00%-14.14M-227.51%-48.38M---27.72M
Profit attributable to shareholders 20.34%-70.05M-5.35%-27.21M50.00%-87.94M70.03%-25.83M13.88%-175.89M15.04%-86.19M43.50%-204.24M49.23%-101.44M-11.04%-361.45M-1,364.19%-199.79M
Basic earnings per share 19.44%-0.290.00%-0.1150.00%-0.3668.57%-0.1114.29%-0.7216.67%-0.3548.78%-0.8453.85%-0.4231.09%-1.64-0.91
Diluted earnings per share 19.44%-0.290.00%-0.1150.00%-0.3668.57%-0.1114.29%-0.7216.67%-0.3548.78%-0.8453.85%-0.4231.09%-1.64-0.91
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions ----Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor ----Ernst & Young Huaming Accounting Firm (Special General Partnership)--Ernst & Young Huaming Accounting Firm (Special General Partnership)--Ernst & Young--Ernst & Young--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +4.00%
Sample Name
Sample Code
 +2.86%
4
SINOPEC CORP
00386
+2.22%
5
CNOOC
00883
+1.66%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +46.25%
Sample Name
Sample Code
 +33.47%
Sample Name
Sample Code
 +26.48%
4
Loongson Technology Corporation
688047
+24.63%
5
Rockchip Electronics
603893
+19.54%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -